Selank: Research Overview, Mechanism of Action & Lab Supply Standards
A summary of published preclinical research on Selank — a synthetic heptapeptide analogue of tuftsin studied for anxiolytic and nootropic endpoints in rodent models.
What Is Selank?
Selank is a synthetic heptapeptide (Thr-Lys-Pro-Arg-Pro-Gly-Pro) developed at the Institute of Molecular Genetics of the Russian Academy of Sciences. It is an analogue of the endogenous immunomodulatory peptide tuftsin, with a modified structure designed for improved stability and blood-brain barrier penetration in research models.
Most published Selank research originates from Russian academic institutions and has been conducted in rodent models examining anxiety-related behavior, cognitive performance under stress conditions, BDNF expression, and immune system modulation. It has been registered as a pharmaceutical drug in Russia under the name Selanc, though this does not constitute approval in Canada or other Western jurisdictions. All material supplied by ACCUTIDE is strictly for laboratory research use only.
Proposed Mechanisms of Action
GABAergic System Modulation
Preclinical studies suggest Selank interacts with the GABAergic system, with proposed effects on GABA-A receptor sensitivity. This is considered one of the primary proposed mechanisms underlying the anxiolytic behavioral endpoints observed in rodent models.
BDNF Upregulation
Rodent studies have documented Selank's influence on brain-derived neurotrophic factor (BDNF) expression in hippocampal tissue. BDNF is a key neurotrophin involved in synaptic plasticity and neuronal survival, making this pathway of interest to researchers studying neuroplasticity endpoints.
Enkephalin System Interaction
Research has documented Selank's interaction with enkephalinase — an enzyme responsible for degrading endogenous enkephalins. By inhibiting this breakdown, Selank may prolong endogenous enkephalin activity, contributing to anxiolytic and analgesic-related endpoints observed in preclinical models.
Immune & Cytokine Modulation
A subset of Selank studies examines its immunomodulatory properties, with documented effects on interleukin and interferon expression in rodent models. These findings suggest dual anxiolytic and immunological activity — an unusual research profile that has driven continued academic interest in the compound.
Selected Published Research
Kozlovskii VL, et al. — Doklady Biological Sciences, 2012
Rodent study documenting Selank's effect on BDNF expression in hippocampal tissue, with proposed implications for neuroplasticity-related research endpoints.
Semenova TP, et al. — Bulletin of Experimental Biology and Medicine, 2010
Preclinical study examining Selank's influence on behavioral endpoints in rodent anxiety models, including maze performance and stress reactivity measures.
Uchakina ON, et al. — Bulletin of Experimental Biology and Medicine, 2008
Documents dose-dependent anxiolytic behavioral effects in rodent models, with immunological marker analysis suggesting modulation of cytokine profiles alongside behavioral endpoints.
Zozulia AA, et al. — Bulletin of Experimental Biology and Medicine, 2008
Examines Selank's effect on immune-related gene expression in rodent models, with documented changes in interleukin and interferon pathway markers.
Purity Standards for Research Use
HPLC Purity
Research-grade Selank should meet ≥99%+ purity by HPLC. As a heptapeptide, Selank is susceptible to oxidation and hydrolytic degradation — batch-specific HPLC confirmation is essential to verify compound integrity prior to use.
Mass Spectrometry
MS identity confirmation verifies the molecular weight (M = 751.86 g/mol) and fragmentation pattern of Selank, distinguishing it from tuftsin or related analogues that may appear similar in appearance but have different sequences.
Lyophilization
Selank is most stable in lyophilized (freeze-dried) form. Reconstitution should be performed with bacteriostatic water immediately prior to use. Storage at -20°C in lyophilized form is standard for research supply.
Certificate of Analysis
A batch-specific COA documenting HPLC result, MS identity, appearance, and storage conditions is required for institutional procurement. Generic or reused COA documents are not acceptable for research-grade supply.
Sourcing Selank in Canada
ACCUTIDE Research Supply provides Selank tested to ≥99%+ HPLC purity with batch-specific COA and MS identity confirmation. All material is lyophilized and ships Canada-wide with appropriate cold-chain packaging for research use only.
Selank — Canadian Research Supply
≥99%+ HPLC · COA every batch · Ships Canada-wide · RUO
Often Researched With
Compounds frequently co-investigated alongside Selank in preclinical research literature.
Research Use Only Disclaimer: All information is provided for scientific research and educational purposes only. Selank supplied by ACCUTIDE Research Supply is strictly for laboratory and research use (RUO). Not for human or animal consumption. All published studies referenced are preclinical rodent model research conducted primarily in Russian academic institutions.